Shanghai RAAS Blood Products Co., Ltd.

SZSE:002252 Voorraadrapport

Marktkapitalisatie: CN¥48.5b

Shanghai RAAS Blood Products Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Shanghai RAAS Blood Products has a total shareholder equity of CN¥31.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥33.4B and CN¥2.2B respectively. Shanghai RAAS Blood Products's EBIT is CN¥2.3B making its interest coverage ratio -8.5. It has cash and short-term investments of CN¥3.7B.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

CN¥0

Schuld

Rente dekkingsratio-8.5x
ContantCN¥3.71b
AandelenCN¥31.17b
Totaal verplichtingenCN¥2.19b
Totaal activaCN¥33.36b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 002252's short term assets (CN¥9.1B) exceed its short term liabilities (CN¥2.2B).

Langlopende schulden: 002252's short term assets (CN¥9.1B) exceed its long term liabilities (CN¥26.8M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 002252 is debt free.

Schuld verminderen: 002252 had no debt 5 years ago.

Schuldendekking: 002252 has no debt, therefore it does not need to be covered by operating cash flow.

Rentedekking: 002252 has no debt, therefore coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven